Genomics Biotech

UKRI funds three doctoral training centres integrating AI and engineering biology to train PhD cohorts in biocatalysis, protein engineering and microbial bioengineering.

Novartis commits to a $1.7B collaboration with Relation Therapeutics to use AI and multi-omic patient data for faster target discovery in atopic dermatology.

How AI-led start-ups are accelerating drug discovery, precision medicine, and hospital workflows. Practical signals for founders and investors.

Short guide for biotech, pharma and medtech leaders on building AI guardrails that protect patient safety, data integrity and supply chain resilience.

Discover how AI-powered genomic analysis is transforming personalized medicine by accelerating diagnosis and treatment, with implications for healthcare and biotech industries.

Discover how Shookra Aesthetics in Dubai is using AI and biotechnology to pioneer personalized regenerative treatments targeting cellular ageing within the expanding UAE beauty-tech market.

Explore how AI is rapidly changing biotech research, the challenges researchers face in AI adoption, and the essential trust factors needed for responsible integration in scientific discovery.

Explore how AI and machine learning investments are maintaining momentum in the UK biotech sector despite economic shifts, driving innovation and attracting venture capital.

Explore how AI and biotechnology combine to revolutionize active ingredient development through precise molecular design, sustainable sourcing, and evolving regulations shaping the future of health products.

Discover how the EU Biotech Act aims to transform biotechnology by streamlining regulations and accelerating AI-driven innovation across healthcare, agriculture, and industry.